QOLP-05. OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS

INTRODUCTION: Malignant glioma (MG) patients often experience chemotherapy-induced nausea and vomiting (CINV). Olanzapine has recently been added to national anti-emesis guidelines for patients on moderately/highly emetogenic chemotherapy. In this retrospective study, we investigated the use of olan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Patel, Mallika, Peters, Katherine, Lipp, Eric, Low, Justin, Herndon, James, Broadwater, Gloria, Johnson, Margaret, Randazzo, Dina, Kim, Jung-Young, Affronti, Mary
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Quality of Life and Palliative Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651220/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.730
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars